Inhaled nitric oxide for the treatment of COVID-19: an open-label, parallel, randomised controlled trial

The iNO treatment was well tolerated and safe. Among adults hospitalised for COVID-19, iNO 160 ppm for 6 h increased the number of days free from supplemental oxygen, shortened the days of ventilatory support and the length of hospital stay, and improved the clinical score.

Authors

Institutions

Publication Details

Journal
ERJ Open Research
Published
2025-02-06
DOI
https://doi.org/10.1183/23120541.00006-2024
Citations
2
Primary Topic
Respiratory Support and Mechanisms
Type
article
Field-Weighted Citation Impact
3.04
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Inhaled nitric oxide for the treatment of COVID-19: an open-label, parallel, randomised controlled trial

Marcus Herbert Jones, Amanda Paz Santos, Lúcio Lara Santos, Luciana Medeiros Paungartner et al.
2 citations
ERJ Open Research
Respiratory Support and Mechanisms
3.04
article

Inhaled nitric oxide for the treatment of COVID-19: an open-label, parallel, randomised controlled trial

Marcus Herbert Jones, Amanda Paz Santos, Lúcio Lara Santos, Luciana Medeiros Paungartner, Vinicius Schenk Michaelsen, Guilherme Trafani Sanches, Florencia María Barbé‐Tuana, Lucas Kich Grün, Fabiano Ramos, Morgana Thaí­s Carollo Fernandes, Frederico Friedrich, Régis Goulart Rosa, Gustavo Chatkin, Caroline Lantmann, Marcelo Scheffer Maranghello, Marcelo Cypel, Gustavo Eggers, Roberta Di Marco, Marcos Brum, Daniel Rodrigo Marinowic
article en
2 citations

Abstract

The iNO treatment was well tolerated and safe. Among adults hospitalised for COVID-19, iNO 160 ppm for 6 h increased the number of days free from supplemental oxygen, shortened the days of ventilatory support and the length of hospital stay, and improved the clinical score.

ERJ Open ResearchVol. 11(4)
University Health Network (CA), Hospital Moinhos de Vento (BR), Brazilian Research in Intensive Care Network (BR), Hospital São Lucas da PUCRS (BR), Pontifícia Universidade Católica do Rio Grande do Sul (BR)
Openalex Percentile: Top 11%
Respiratory Support and Mechanisms
3.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.